This DARPA grant is for the purpose of funding innovative research proposals focused on developing highly efficacious nucleic acid-based vaccines. The program seeks novel ideas for discovering, designing, evolving, and assembling genetic components, modules, and circuits. The ultimate goal is to demonstrate the capability to create vaccines whose activity can be precisely regulated in vivo by a mammalian host, offering advanced control over vaccine performance. This initiative aims to push the boundaries of vaccine technology through the sophisticated manipulation of cellular machinery at a genetic level, ensuring responsiveness and efficacy within biological systems. The research should explore how to achieve robust, controllable vaccine action using cutting-edge genetic engineering.
Opportunity ID: 58911
General Information
| Document Type: | Grants Notice |
| Funding Opportunity Number: | DARPA-BAA-11-22 |
| Funding Opportunity Title: | Controlling Cellular Machinery – Vaccines |
| Opportunity Category: | Discretionary |
| Opportunity Category Explanation: | – |
| Funding Instrument Type: | Other |
| Category of Funding Activity: | Science and Technology and other Research and Development |
| Category Explanation: | – |
| Expected Number of Awards: | – |
| Assistance Listings: | 12.910 — Research and Technology Development |
| Cost Sharing or Matching Requirement: | No |
| Version: | Synopsis 2 |
| Posted Date: | Nov 29, 2010 |
| Last Updated Date: | Jan 28, 2011 |
| Original Closing Date for Applications: | Feb 16, 2011 |
| Current Closing Date for Applications: | Feb 16, 2011 |
| Archive Date: | Apr 15, 2011 |
| Estimated Total Program Funding: | – |
| Award Ceiling: | – |
| Award Floor: | – |
Eligibility
| Eligible Applicants: | Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled “Additional Information on Eligibility” |
| Additional Information on Eligibility: | – |
Additional Information
| Agency Name: | DARPA – Defense Sciences Office |
| Description: | DARPA is soliciting innovative research proposals with new ideas about how to discover, design, evolve, assemble and demonstrate the ability to use genetic components, modules and circuits for the development of a highly efficacious nucleic acid based vaccine whose activity can be regulated in vivo by a mammalian host. See attached DARPA-BAA-11-22. |
| Link to Additional Information: | DARPA-BAA-11-22 |
| Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
DARPA BAA COORDINATOR
Email:DARPA-BAA-11-22@darpa.mil |
Version History
| Version | Modification Description | Updated Date |
|---|---|---|
| Modification 1 to DARPA-BAA-11-22 Controlling Cellular Machinery – Vaccines is to update the Program Metrics.
See attached Modification 1 to DARPA-BAA-11-22. |
Jan 28, 2011 | |
| Jan 28, 2011 |
DISPLAYING: Synopsis 2
General Information
| Document Type: | Grants Notice |
| Funding Opportunity Number: | DARPA-BAA-11-22 |
| Funding Opportunity Title: | Controlling Cellular Machinery – Vaccines |
| Opportunity Category: | Discretionary |
| Opportunity Category Explanation: | – |
| Funding Instrument Type: | Other |
| Category of Funding Activity: | Science and Technology and other Research and Development |
| Category Explanation: | – |
| Expected Number of Awards: | – |
| Assistance Listings: | 12.910 — Research and Technology Development |
| Cost Sharing or Matching Requirement: | No |
| Version: | Synopsis 2 |
| Posted Date: | Nov 29, 2010 |
| Last Updated Date: | Jan 28, 2011 |
| Original Closing Date for Applications: | Feb 16, 2011 |
| Current Closing Date for Applications: | Feb 16, 2011 |
| Archive Date: | Apr 15, 2011 |
| Estimated Total Program Funding: | – |
| Award Ceiling: | – |
| Award Floor: | – |
Eligibility
| Eligible Applicants: | Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled “Additional Information on Eligibility” |
| Additional Information on Eligibility: | – |
Additional Information
| Agency Name: | DARPA – Defense Sciences Office |
| Description: | DARPA is soliciting innovative research proposals with new ideas about how to discover, design, evolve, assemble and demonstrate the ability to use genetic components, modules and circuits for the development of a highly efficacious nucleic acid based vaccine whose activity can be regulated in vivo by a mammalian host. See attached DARPA-BAA-11-22. |
| Link to Additional Information: | DARPA-BAA-11-22 |
| Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
DARPA BAA COORDINATOR
Email:DARPA-BAA-11-22@darpa.mil |
DISPLAYING: Synopsis 1
General Information
| Document Type: | Grants Notice |
| Funding Opportunity Number: | DARPA-BAA-11-22 |
| Funding Opportunity Title: | Controlling Cellular Machinery – Vaccines |
| Opportunity Category: | Discretionary |
| Opportunity Category Explanation: | – |
| Funding Instrument Type: | Other |
| Category of Funding Activity: | Science and Technology and other Research and Development |
| Category Explanation: | – |
| Expected Number of Awards: | – |
| Assistance Listings: | 12.910 — Research and Technology Development |
| Cost Sharing or Matching Requirement: | No |
| Version: | Synopsis 1 |
| Posted Date: | Jan 28, 2011 |
| Last Updated Date: | – |
| Original Closing Date for Applications: | – |
| Current Closing Date for Applications: | Feb 16, 2011 |
| Archive Date: | Apr 15, 2011 |
| Estimated Total Program Funding: | – |
| Award Ceiling: | – |
| Award Floor: | – |
Eligibility
| Eligible Applicants: | Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled “Additional Information on Eligibility” |
| Additional Information on Eligibility: | – |
Additional Information
| Agency Name: | DARPA – Defense Sciences Office |
| Description: | DARPA is soliciting innovative research proposals with new ideas about how to discover, design, evolve, assemble and demonstrate the ability to use genetic components, modules and circuits for the development of a highly efficacious nucleic acid based vaccine whose activity can be regulated in vivo by a mammalian host. See attached DARPA-BAA-11-22. |
| Link to Additional Information: | DARPA-BAA-11-22 |
| Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
DARPA BAA COORDINATOR
Email:DARPA-BAA-11-22@darpa.mil |
Related Documents
Folder 58911 Full Announcement-1 -> baa darpa-baa-11-22.pdf
Folder 58911 Revised Full Announcement-1 -> darpa-baa-11-22 modification 1.pdf
Packages
| Agency Contact Information: | DARPA BAA COORDINATOR Email: DARPA-BAA-11-22@darpa.mil |
| Who Can Apply: | Organization Applicants |
| Assistance Listing Number | Competition ID | Competition Title | Opportunity Package ID | Opening Date | Closing Date | Actions |
|---|---|---|---|---|---|---|
| 12.910 | PKG00022668 | Nov 29, 2010 | Feb 16, 2011 | View |
Package 1
Mandatory forms
58911 RR_SF424-1.1.pdf
Optional forms
58911 RR_FedNonFedBudget-1.1.pdf
58911 RR_FedNonFed_SubawardBudget-1.2.pdf
58911 RR_OtherProjectInfo-1.1.pdf
58911 RR_Budget-1.1.pdf
58911 RR_KeyPersonExpanded-1.1.pdf
58911 RR_PerformanceSite-1.1.pdf
58911 RR_SubawardBudget-1.2.pdf
Share This Post, Choose Your Platform!
About the Author: osnqt
